PISCATAWAY, N.J, April 1, 2020 /PRNewswire/ -- GenScript, a world leading biotechnology company, today announced the commercial launch of its neoantigen peptide synthesis service for biotech and ...

GenScript can synthesize numerous difficult neoantigen peptides and offer specialized optimization tools for specific downstream applications. They have the technical capability and experience to ...

Peptides have emerged as indispensable tools in modern drug discovery, playing a central role in areas such as oncology, metabolic disorders, targeted delivery, and protein–protein interaction ...

Vapourtec’s Peptide-Builder, a fully automated, high-throughput benchtop peptide synthesiser, has been designed to redefine solid-phase peptide synthesis (SPPS). Compact, efficient and intuitive, it ...

Chemical synthesis and peptide ligation techniques have revolutionised the field of protein engineering by enabling the precise construction of peptides and proteins with tailored modifications. These ...

There has been a recent revival in interest in peptide therapeutic development, with five of the top-selling drugs being peptides or proteins (Enbrel, Remicade, Humira, Avastin, MabThera) and many ...

In May, TheraCode acquired JPT Peptide Technologies, a wholly owned subsidiary of Jerini. JPT offers peptide-based products and services for vaccine development, immune monitoring, and peptide ...

What is it? As the name suggests, nonribosomal peptide synthesis (NRPS) generates polypeptides sans ribosome. The resultant peptides, generally short oligomers of two to perhaps 48 residues, are not ...

The global Peptide Synthesis Market is valued at USD 649.6 Million in 2024 and is projected to reach a value of USD 1660.1 Million by 2035 at a CAGR of 8.91% between 2025 and 2035. The Peptide ...

Proteins sourced from microorganisms are attracting attention for their potential in biomanufacturing a variety of products, ...